In this review, we highlight the regulation and mechanism of the Hippo-YAP1/TAZ pathway in metabolism disorders, cellular senescence, ferroptosis, inflammation, and fibrosis on the progression of MASLD, which may offer new insights for developing effective treatment strategies for MASLD. Here, YAP1 is linked to metabolic dysfunction-associated steatotic liver disease.